Dr. Gómez-Touriño Masters’ and PhD focused in autoantigen epitope identification, autoantibodies and galectins in the autoimmune disease Type 1 Diabetes (T1D). To acquire experience in the animal model of T1D she stayed for 6 months in the Germans Trias i Pujol Institute on Health Sciences. She presented her thesis on September 2011 (cum laude and extraordinary award).
She then pursued postdoctoral training abroad (Oct 2012-Apr 2017) in the Immunobiology Dpt. at King’s College London (UK), studying the autoreactive T cells that lead to the destruction of the pancreas during T1D, both functionally through single-cell transcriptomics and structurally through T cell receptor repertoire analysis. This postdoctoral stage included 2 stays in the Technische Universität Dresden (Germany) and work in 2 immunotherapy clinical trials.
In 2014 she received the Award to the best research career in the V Meeting of Young Researchers (Fundación Barrié and UDC).
Since May 2017 she works in vaccine development in autoimmunity in the Immunology group of the Biomedical Research Centre (University of Vigo, Spain).